Product
ChAd155-RG
1 clinical trial
2 indications
Indication
RabiesIndication
Rabies ImmunisationClinical trial
A Phase 1, Dosage-Escalation Study of the Safety and Immunogenicity of a Novel Rabies Vaccine ChAd155-RG vs. the Comparator RABAVERT Vaccine in Healthy Adult SubjectsStatus: Completed, Estimated PCD: 2023-03-24